Evidence map›Paper›PMID 24710214›Full record

ArticleGenes2011

Genes Involved in the Production of Antimetabolite Toxins by Pseudomonas syringae Pathovars.

Eva Arrebola, Francisco M Cazorla, Alejandro Pérez-García, Antonio de Vicente

Open access · goldAbstract read
In one paragraph

Article in Genes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in plant science · 2019
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eva ArrebolaExperimental Station La Mayora, Institute of Subtropical Horticulture and Mediterranean "La Mayora" (IHSM-UMA-CSIC), Algarrobo-Costa (Málaga) 29750, Spain. arrebolad@eelm.csic.es.
Francisco M CazorlaMicrobiology Department, Institute of Subtropical Horticultural and Mediterranean "La Mayora" (IHSM-UMA-CSIC), Faculty of Science, University of Málaga, Associated Unit with the CSIC, Campus de Teatinos, Málaga 29071, Spain. cazorla@uma.es.
Alejandro Pérez-GarcíaMicrobiology Department, Institute of Subtropical Horticultural and Mediterranean "La Mayora" (IHSM-UMA-CSIC), Faculty of Science, University of Málaga, Associated Unit with the CSIC, Campus de Teatinos, Málaga 29071, Spain. aperez@uma.es.
Antonio de VicenteMicrobiology Department, Institute of Subtropical Horticultural and Mediterranean "La Mayora" (IHSM-UMA-CSIC), Faculty of Science, University of Málaga, Associated Unit with the CSIC, Campus de Teatinos, Málaga 29071, Spain. adevicente@uma.es.
Instituto de Hortofruticultura Subtropical y Mediterránea "La Mayora" · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas syringae is pathogenic in a wide variety of plants, causing diseases with economic impacts. Pseudomonas syringae pathovars produce several toxins that can function as virulence factors and contribute to disease symptoms. These virulence factors include antimetabolite toxins, such as tabtoxin, phaseolotoxin and mangotoxin, which target enzymes in the pathways of amino acid metabolism. The antimetabolite toxins are generally located in gene clusters present in the flexible genomes of specific strains. These gene clusters are typically present in blocks of genes that appear to be integrated into specific sites in the P. syringae core genome. A general overview of the genetic organization and biosynthetic and regulatory functions of these genetic traits of the antimetabolite toxins will be given in the present work.

Identifiers

PMID24710214
PMCPMC3927611
OpenAlexW2152992431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.